Effects of Bifidobacterium animalis Subsp. Lactis CP‐9 on Gut Microbiota and Immune Functions in Healthy Infants
Liujing Zhang, Xueke Song, Keming Zhang, Xiaoshuang Xu, Xinmei Guo, Wei Li, Xiaoling Zeng, Yingguang Xie, Liwei Nie, Li Zhao, Xuelu Dai, Jing Sun, Jiai Yan, Yiran Liu, Feng Zhang, Zhiping Sun · 2026
Read Effects of Bifidobacterium animalis Subsp. Lactis CP‐9 on Gut Microbiota and Immune Functions in Healthy Infants by Liujing Zhang, Xueke Song, Keming Zhang, Xiaoshuang Xu, Xinmei Guo, Wei Li, Xiaoling Zeng, Yingguang Xie, Liwei Nie, Li Zhao, Xuelu Dai, Jing Sun, Jiai Yan, Yiran Liu, Feng Zhang, Zhiping Sun (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13420211.txt.
Description
Liujing Zhang and colleagues test a probiotic strain called CP-9, a form of Bifidobacterium animalis, in healthy infants. Their 2026 randomised, double-blind, placebo-controlled trial examines gut microbes, immune markers, and safety in babies aged six to thirty-six months.
Infants received CP-9 or a placebo for three months, with growth, blood counts, immune markers, and stool microbes measured before and after. All infants grew appropriately in height and head circumference. The probiotic significantly raised gut Bifidobacterium levels and shifted a pathway that builds polyunsaturated fatty acids. Blood and inflammation markers stayed in normal ranges, stools improved, and rates of allergy or respiratory infection did not rise. The authors conclude CP-9 showed no obvious short-term safety concerns in this age group.
Catalog record
| CREATOR | Liujing Zhang, Xueke Song, Keming Zhang, Xiaoshuang Xu, Xinmei Guo, Wei Li, Xiaoling Zeng, Yingguang Xie, Liwei Nie, Li Zhao, Xuelu Dai, Jing Sun, Jiai Yan, Yiran Liu, Feng Zhang, Zhiping Sun |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |